Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study

BackgroundThere is limited information regarding the optimal third-line therapy for managing type 2 diabetes mellitus (T2DM) that is inadequately controlled using dual combination therapy. This study assessed the efficacy and safety of pioglitazone or glimepiride when added to metformin plus aloglip...

Full description

Bibliographic Details
Main Authors: Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee, Young Sik Choi, Duk Kyu Kim, In Joo Kim
Format: Article
Language:English
Published: Korean Diabetes Association 2020-02-01
Series:Diabetes & Metabolism Journal
Subjects:
dipeptidyl-peptidase iv inhibitors
drug therapy, combination
sulfonylurea compounds
thiazolidinediones
treatment failure
Online Access:http://e-dmj.org/upload/pdf/dmj-44-67.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-44-67.pdf

Similar Items